Global Telehealth for Women’s Reproductive and Sexual Health Market

Telehealth for Women’s Reproductive and Sexual Health Comprehensive Study by Type (Home Telehealth Monitoring Devices, Home Telehealth Services, Telehealth Software Solutions), Application (Birth Control, PMS, Pelvic Pain, STD Prevention, Menopause, Postpartum Depression, Others), Services (Consulting Services, Diagnostic/Testing Services, Drug Delivery, Others)

Telehealth for Women’s Reproductive and Sexual Health Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Telehealth for Women’s Reproductive and Sexual Health
Telehealth as the provision of health care services by health care professionals, utilizing technology to exchange information in the treatment and prevention of disease. It is increasingly recognised that telehealth services reduce waiting times and increase patient satisfaction. Telehealth may improve access for underserved populations and those facing barriers to care. Women are increasingly turning to digital technology to manage all aspects of their lives.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


The key manufacturers are targeting the innovations of the products with better quality, better technical characteristics, and also assist in providing and humanizing the after-sale service to the consumers. The key players are probable to keep a stronghold on the market over the anticipated period. The key players are accepting strategic decisions and are thinking upon mergers and acquisitions in order to maintain their presence in the market. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Telehealth for Women’s Reproductive and Sexual Health market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

HeyDoctor (United States), Limited Liability Company (United States), Icebreaker (New Zealand), Maven Clinic Co. (United States), NURX Inc. (United States), Pandia Health, Inc. (United States), PILL CLUB (United States), Myovant Sciences (United Kingdom), Hologic (United States) and Dare Bioscience (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Telehealth for Women’s Reproductive and Sexual Health market by Type (Home Telehealth Monitoring Devices, Home Telehealth Services and Telehealth Software Solutions), Application (Birth Control, PMS, Pelvic Pain, STD Prevention, Menopause, Postpartum Depression and Others) and Region.



On the basis of geography, the market of Telehealth for Women’s Reproductive and Sexual Health has been segmented into . If we see Market by Services, the sub-segment i.e. Consulting Services will boost the Telehealth for Women’s Reproductive and Sexual Health market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Trend of Telehealth for Women Sexual Health Due to Telehealth is a more affordable option than traditional treatment and Rise Due to unequal access to technology and awareness to address the lowered availability of clinic-based services during the pandemic

Market Growth Drivers:
Rise in Use of Virtual healthcare services are becoming more popular as smartphone, Increase access to sexual and reproductive health services in some countries during the COVID-19 pandemic and Women are increasingly turning to digital technology to manage all aspects of their lives

Challenges:
Challenge to Integrate Innovative Digital Health Care Delivery Options

Restraints:
Telehealth could also widen disparities due to the differences in internet access and digital literacy

Opportunities:
Telemedicine has long been hailed as a way to improve access to healthcare, particularly in rural areas with a shortage of clinicians, Growing Telehealth opportunities for sexual and reproductive health care during the COVID-19 pandemic and Increasing New Number of Investors in Telehealth for Women

Market Leaders and their expansionary development strategies
On FEB 10TH 2022, San Francisco's Nurx and New York-based Thirty Madison announced that they will merge and operate under the Thirty Madison brand. Terms were not disclosed, but Nurx was valued at more than USD 300 million in 2020, according to PitchBook.
On 21st October 2021, Telemedicine is among the services provided by Saúde das Manas (which translates to Sisters’ Health), a partnership between UNFPA and the Council of Municipal Health Departments of Pará. Launched in August 2020, the project was intended to increase access to sexual and reproductive health services in the Marajó Archipelago during the COVID-19 pandemic. However, it has since been expanded to cover a variety of other medical specialties, urology, pulmonology and dermatology, among others.


Key Target Audience
Telehealth for Women’s Reproductive and Sexual Health Equipment Manufacturers, Telehealth for Women’s Reproductive and Sexual Health Service Providers, Telehealth for Women’s Reproductive and Sexual Health Software Vendor, Regulatory Bodies, Potential Investors, Research and Development Institutes and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Home Telehealth Monitoring Devices
  • Home Telehealth Services
  • Telehealth Software Solutions
By Application
  • Birth Control
  • PMS
  • Pelvic Pain
  • STD Prevention
  • Menopause
  • Postpartum Depression
  • Others
By Services
  • Consulting Services
  • Diagnostic/Testing Services
  • Drug Delivery
  • Others

By Regions
    • 1. Market Overview
      • 1.1. Introduction
      • 1.2. Scope/Objective of the Study
        • 1.2.1. Research Objective
    • 2. Executive Summary
      • 2.1. Introduction
    • 3. Market Dynamics
      • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. Rise in Use of Virtual healthcare services are becoming more popular as smartphone
        • 3.2.2. Increase access to sexual and reproductive health services in some countries during the COVID-19 pandemic
        • 3.2.3. Women are increasingly turning to digital technology to manage all aspects of their lives
      • 3.3. Market Challenges
        • 3.3.1. Challenge to Integrate Innovative Digital Health Care Delivery Options
      • 3.4. Market Trends
        • 3.4.1. Increasing Trend of Telehealth for Women Sexual Health Due to Telehealth is a more affordable option than traditional treatment
        • 3.4.2. Rise Due to unequal access to technology and awareness to address the lowered availability of clinic-based services during the pandemic
    • 4. Market Factor Analysis
      • 4.1. Porters Five Forces
      • 4.2. Supply/Value Chain
      • 4.3. PESTEL analysis
      • 4.4. Market Entropy
      • 4.5. Patent/Trademark Analysis
    • 5. Global Telehealth for Women’s Reproductive and Sexual Health, by Type, Application and Services (value and price ) (2016-2021)
      • 5.1. Introduction
      • 5.2. Global Telehealth for Women’s Reproductive and Sexual Health (Value)
        • 5.2.1. Global Telehealth for Women’s Reproductive and Sexual Health by: Type (Value)
          • 5.2.1.1. Home Telehealth Monitoring Devices
          • 5.2.1.2. Home Telehealth Services
          • 5.2.1.3. Telehealth Software Solutions
        • 5.2.2. Global Telehealth for Women’s Reproductive and Sexual Health by: Application (Value)
          • 5.2.2.1. Birth Control
          • 5.2.2.2. PMS
          • 5.2.2.3. Pelvic Pain
          • 5.2.2.4. STD Prevention
          • 5.2.2.5. Menopause
          • 5.2.2.6. Postpartum Depression
          • 5.2.2.7. Others
        • 5.2.3. Global Telehealth for Women’s Reproductive and Sexual Health by: Services (Value)
          • 5.2.3.1. Consulting Services
          • 5.2.3.2. Diagnostic/Testing Services
          • 5.2.3.3. Drug Delivery
          • 5.2.3.4. Others
      • 5.3. Global Telehealth for Women’s Reproductive and Sexual Health (Price)
        • 5.3.1. Global Telehealth for Women’s Reproductive and Sexual Health by: Type (Price)
    • 6. Telehealth for Women’s Reproductive and Sexual Health: Manufacturers/Players Analysis
      • 6.1. Competitive Landscape
        • 6.1.1. Market Share Analysis
          • 6.1.1.1. Top 3
          • 6.1.1.2. Top 5
      • 6.2. Peer Group Analysis (2021)
      • 6.3. BCG Matrix
      • 6.4. Company Profile
        • 6.4.1. HeyDoctor (United States)
          • 6.4.1.1. Business Overview
          • 6.4.1.2. Products/Services Offerings
          • 6.4.1.3. Financial Analysis
          • 6.4.1.4. SWOT Analysis
        • 6.4.2. Limited Liability Company (United States)
          • 6.4.2.1. Business Overview
          • 6.4.2.2. Products/Services Offerings
          • 6.4.2.3. Financial Analysis
          • 6.4.2.4. SWOT Analysis
        • 6.4.3. Icebreaker (New Zealand)
          • 6.4.3.1. Business Overview
          • 6.4.3.2. Products/Services Offerings
          • 6.4.3.3. Financial Analysis
          • 6.4.3.4. SWOT Analysis
        • 6.4.4. Maven Clinic Co. (United States)
          • 6.4.4.1. Business Overview
          • 6.4.4.2. Products/Services Offerings
          • 6.4.4.3. Financial Analysis
          • 6.4.4.4. SWOT Analysis
        • 6.4.5. NURX Inc. (United States)
          • 6.4.5.1. Business Overview
          • 6.4.5.2. Products/Services Offerings
          • 6.4.5.3. Financial Analysis
          • 6.4.5.4. SWOT Analysis
        • 6.4.6. Pandia Health, Inc. (United States)
          • 6.4.6.1. Business Overview
          • 6.4.6.2. Products/Services Offerings
          • 6.4.6.3. Financial Analysis
          • 6.4.6.4. SWOT Analysis
        • 6.4.7. PILL CLUB (United States)
          • 6.4.7.1. Business Overview
          • 6.4.7.2. Products/Services Offerings
          • 6.4.7.3. Financial Analysis
          • 6.4.7.4. SWOT Analysis
        • 6.4.8. Myovant Sciences (United Kingdom)
          • 6.4.8.1. Business Overview
          • 6.4.8.2. Products/Services Offerings
          • 6.4.8.3. Financial Analysis
          • 6.4.8.4. SWOT Analysis
        • 6.4.9. Hologic (United States)
          • 6.4.9.1. Business Overview
          • 6.4.9.2. Products/Services Offerings
          • 6.4.9.3. Financial Analysis
          • 6.4.9.4. SWOT Analysis
        • 6.4.10. Dare Bioscience (United States)
          • 6.4.10.1. Business Overview
          • 6.4.10.2. Products/Services Offerings
          • 6.4.10.3. Financial Analysis
          • 6.4.10.4. SWOT Analysis
    • 7. Global Telehealth for Women’s Reproductive and Sexual Health Sale, by Type, Application and Services (value and price ) (2022-2027)
      • 7.1. Introduction
      • 7.2. Global Telehealth for Women’s Reproductive and Sexual Health (Value)
        • 7.2.1. Global Telehealth for Women’s Reproductive and Sexual Health by: Type (Value)
          • 7.2.1.1. Home Telehealth Monitoring Devices
          • 7.2.1.2. Home Telehealth Services
          • 7.2.1.3. Telehealth Software Solutions
        • 7.2.2. Global Telehealth for Women’s Reproductive and Sexual Health by: Application (Value)
          • 7.2.2.1. Birth Control
          • 7.2.2.2. PMS
          • 7.2.2.3. Pelvic Pain
          • 7.2.2.4. STD Prevention
          • 7.2.2.5. Menopause
          • 7.2.2.6. Postpartum Depression
          • 7.2.2.7. Others
        • 7.2.3. Global Telehealth for Women’s Reproductive and Sexual Health by: Services (Value)
          • 7.2.3.1. Consulting Services
          • 7.2.3.2. Diagnostic/Testing Services
          • 7.2.3.3. Drug Delivery
          • 7.2.3.4. Others
      • 7.3. Global Telehealth for Women’s Reproductive and Sexual Health (Price)
        • 7.3.1. Global Telehealth for Women’s Reproductive and Sexual Health by: Type (Price)
    • 8. Appendix
      • 8.1. Acronyms
    • 9. Methodology and Data Source
      • 9.1. Methodology/Research Approach
        • 9.1.1. Research Programs/Design
        • 9.1.2. Market Size Estimation
        • 9.1.3. Market Breakdown and Data Triangulation
      • 9.2. Data Source
        • 9.2.1. Secondary Sources
        • 9.2.2. Primary Sources
      • 9.3. Disclaimer
    List of Tables
    • Table 1. Telehealth for Women’s Reproductive and Sexual Health: by Type(USD Million)
    • Table 2. Telehealth for Women’s Reproductive and Sexual Health: by Application(USD Million)
    • Table 3. Telehealth for Women’s Reproductive and Sexual Health: by Services(USD Million)
    • Table 4. Telehealth for Women’s Reproductive and Sexual Health: by Type(USD/Units)
    • Table 5. Company Basic Information, Sales Area and Its Competitors
    • Table 6. Company Basic Information, Sales Area and Its Competitors
    • Table 7. Company Basic Information, Sales Area and Its Competitors
    • Table 8. Company Basic Information, Sales Area and Its Competitors
    • Table 9. Company Basic Information, Sales Area and Its Competitors
    • Table 10. Company Basic Information, Sales Area and Its Competitors
    • Table 11. Company Basic Information, Sales Area and Its Competitors
    • Table 12. Company Basic Information, Sales Area and Its Competitors
    • Table 13. Company Basic Information, Sales Area and Its Competitors
    • Table 14. Company Basic Information, Sales Area and Its Competitors
    • Table 15. Telehealth for Women’s Reproductive and Sexual Health: by Type(USD Million)
    • Table 16. Telehealth for Women’s Reproductive and Sexual Health: by Application(USD Million)
    • Table 17. Telehealth for Women’s Reproductive and Sexual Health: by Services(USD Million)
    • Table 18. Telehealth for Women’s Reproductive and Sexual Health: by Type(USD/Units)
    • Table 19. Research Programs/Design for This Report
    • Table 20. Key Data Information from Secondary Sources
    • Table 21. Key Data Information from Primary Sources
    List of Figures
    • Figure 1. Porters Five Forces
    • Figure 2. Supply/Value Chain
    • Figure 3. PESTEL analysis
    • Figure 4. Global Telehealth for Women’s Reproductive and Sexual Health: by Type USD Million (2016-2021)
    • Figure 5. Global Telehealth for Women’s Reproductive and Sexual Health: by Application USD Million (2016-2021)
    • Figure 6. Global Telehealth for Women’s Reproductive and Sexual Health: by Services USD Million (2016-2021)
    • Figure 7. Global Telehealth for Women’s Reproductive and Sexual Health: by Type USD/Units (2016-2021)
    • Figure 8. Global Telehealth for Women’s Reproductive and Sexual Health share by Players 2021 (%)
    • Figure 9. Global Telehealth for Women’s Reproductive and Sexual Health share by Players (Top 3) 2021(%)
    • Figure 10. Global Telehealth for Women’s Reproductive and Sexual Health share by Players (Top 5) 2021(%)
    • Figure 11. BCG Matrix for key Companies
    • Figure 12. HeyDoctor (United States) Revenue, Net Income and Gross profit
    • Figure 13. HeyDoctor (United States) Revenue: by Geography 2021
    • Figure 14. Limited Liability Company (United States) Revenue, Net Income and Gross profit
    • Figure 15. Limited Liability Company (United States) Revenue: by Geography 2021
    • Figure 16. Icebreaker (New Zealand) Revenue, Net Income and Gross profit
    • Figure 17. Icebreaker (New Zealand) Revenue: by Geography 2021
    • Figure 18. Maven Clinic Co. (United States) Revenue, Net Income and Gross profit
    • Figure 19. Maven Clinic Co. (United States) Revenue: by Geography 2021
    • Figure 20. NURX Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 21. NURX Inc. (United States) Revenue: by Geography 2021
    • Figure 22. Pandia Health, Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 23. Pandia Health, Inc. (United States) Revenue: by Geography 2021
    • Figure 24. PILL CLUB (United States) Revenue, Net Income and Gross profit
    • Figure 25. PILL CLUB (United States) Revenue: by Geography 2021
    • Figure 26. Myovant Sciences (United Kingdom) Revenue, Net Income and Gross profit
    • Figure 27. Myovant Sciences (United Kingdom) Revenue: by Geography 2021
    • Figure 28. Hologic (United States) Revenue, Net Income and Gross profit
    • Figure 29. Hologic (United States) Revenue: by Geography 2021
    • Figure 30. Dare Bioscience (United States) Revenue, Net Income and Gross profit
    • Figure 31. Dare Bioscience (United States) Revenue: by Geography 2021
    • Figure 32. Global Telehealth for Women’s Reproductive and Sexual Health: by Type USD Million (2022-2027)
    • Figure 33. Global Telehealth for Women’s Reproductive and Sexual Health: by Application USD Million (2022-2027)
    • Figure 34. Global Telehealth for Women’s Reproductive and Sexual Health: by Services USD Million (2022-2027)
    • Figure 35. Global Telehealth for Women’s Reproductive and Sexual Health: by Type USD/Units (2022-2027)
    List of companies from research coverage that are profiled in the study
    • HeyDoctor (United States)
    • Limited Liability Company (United States)
    • Icebreaker (New Zealand)
    • Maven Clinic Co. (United States)
    • NURX Inc. (United States)
    • Pandia Health, Inc. (United States)
    • PILL CLUB (United States)
    • Myovant Sciences (United Kingdom)
    • Hologic (United States)
    • Dare Bioscience (United States)
    Select User Access Type

    Key Highlights of Report


    Sep 2022 228 Pages 58 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

    Request Sample Pages

    Budget constraints? Get in touch with us for special pricing


    Check Discount Now
    Global Telehealth for Women’s Reproductive and Sexual Health Market Quantitative research analysis
    Global Telehealth for Women’s Reproductive and Sexual Health Market Qualitative Industry Analysis
    DOWNLOAD SAMPLE PDF

    Talk to Our Experts

    Want to Customize Study?


    "We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

    Make an Enquiry Now

    Frequently Asked Questions (FAQ):

    The standard version of the report profiles players such as HeyDoctor (United States), Limited Liability Company (United States), Icebreaker (New Zealand), Maven Clinic Co. (United States), NURX Inc. (United States), Pandia Health, Inc. (United States), PILL CLUB (United States), Myovant Sciences (United Kingdom), Hologic (United States) and Dare Bioscience (United States) etc.
    The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
    "Increasing Trend of Telehealth for Women Sexual Health Due to Telehealth is a more affordable option than traditional treatment " is seen as one of major influencing trends for Telehealth for Women’s Reproductive and Sexual Health Market during projected period 2021-2027.
    The Telehealth for Women’s Reproductive and Sexual Health market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

    Know More About Global Telehealth for Women’s Reproductive and Sexual Health Market Report?

    Have a Query? Click Here

    Other Related Reports

    Medical Gas Supply System Comprehensive Study by Type (Medical Centre Oxygen Supply System, Medical Centre Attraction System, Medical Air Compression System), Application (Therapeutic, Diagnostics, P...
    $ 3800
    Clinical Alert and Notification Systems Comprehensive Study by Type (Panic Button, Pull Cord, Others), Application (Hospitals, Clinics, Ambulatory Surgical Centres, Long Term Care Centres, Others), R...
    $ 3800
    Bio Decomposable Sanitary Napkin Comprehensive Study by Type (Winged, Non-winged), Application (Consumer Industry, Healthcare industry), Distribution Channel (Pharmacy, Organic Stores, Online, Superm...
    $ 3800
    Personal Care Services Comprehensive Study by Type (Diet and Weight Reducing Canters, Beauty Salons, Spas and Massage Parlour, Other Personal Care Services), Application (Body Beauty Salons, Hair Sal...
    $ 3800
    Hair Loss & Growth Treatments and Product Comprehensive Study by End User Industry (Dermatology Clinic, Home Care Setting, Others), Product Type (Form, Shampoo, Spray, Serum, Tablet, Mask, Conditione...
    $ 3800
    Hepatitis B Vaccine Consumption- Comprehensive Study by Type (Single Antigen, Combination), Distribution Channel (Hospitals, Vaccination Centres, Specialty Clinics, Government Suppliers, Others), Dos...
    $ 3800